Accuray (ARAY) – Company Press Releases
-
Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
-
Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
-
New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
-
Accuray Incorporated to Speak at 36th Annual Roth Conference
-
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
-
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Accuray Reports Fiscal 2024 Second Quarter Financial Results
-
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
-
Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024
-
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System
-
Accuray Reports Fiscal 2024 First Quarter Financial Results
-
Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference
-
Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023
-
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration
-
Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
-
Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care
-
Accuray to Host Investor Day at ASTRO on October 3, 2023
-
Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market
-
Accuray Reports Fourth Quarter and Fiscal 2023 Financial Results
-
Accuray to Report Fiscal Year-End 2023 Financial Results on August 9, 2023
-
Accuray Incorporated Announces Its Addition to the Russell 2000® Index
-
Cognizant is Partnering with Accuray to Accelerate Corporate Transformation and Drive Operational Efficiency in Their Radiation Therapy Business
-
Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023
-
Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness
-
Accuray Reports Fiscal 2023 Third Quarter Financial Results
-
Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023
-
Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference
-
Accuray to Participate in the Cowen 43rd Annual Health Care Conference
-
Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
-
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Accuray Reports Fiscal 2023 Second Quarter Financial Results
-
Robert C. Kill Joins Accuray Board of Directors
-
European Radiosurgery Center Munich Invests in Second Accuray CyberKnife® System to Support the Demand for High-Precision Radiosurgery Treatments
-
Accuray to Report Second Quarter Fiscal 2023 Financial Results on February 1, 2023
-
Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device
-
Accuray to Participate in the B. Riley Securities' 3rd Annual Oncology Conference
-
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
-
Accuray Receives IMV Award for Best In Service in Radiation Oncology for 2022
-
Oscar Lambret Center in France Installs Second Accuray Radixact® System, the Hospital's Fifth Accuray Radiation Therapy Delivery System
-
Accuray Reports Fiscal 2023 First Quarter Financial Results
-
Accuray Announces Tomo® C Registration Submission to China's National Medical Products Administration
-
New Reimbursement Approved by the Japanese Ministry of Health, Labor and Welfare for the Accuray CyberKnife® System to Treat Trigeminal Neuralgia, a Condition Often Causing Severe Facial Pain
-
GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy
-
Accuray to Report First Quarter Fiscal 2023 Financial Results on November 2, 2022
-
Accuray and C-RAD Unveil Automated Breast Cancer Treatment Package for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting
-
Data Published in The Lancet Oncology Indicate Men With Prostate Cancer Treated With the Accuray CyberKnife® Platform Experienced a Lower Incidence of Bladder Side Effects Than Those Treated With Con
-
Accuray to Host Meeting with Analysts and Investors at ASTRO on October 24, 2022
-
Accuray Announces First CyberKnife® Systems in Africa, Providing a New Option and Hope for Potentially Life-Saving Radiation Treatments for More Cancer Patients
-
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Back to ARAY Stock Lookup
